Johnson & Johnson (NYSE:JNJ) shares rose 1.3% to $268.96 in pre-market trading on Monday following a report that Apollo Global Management (NYSE:APO) is in discussions to acquire the healthcare group’s orthopedics business.
Bloomberg News reported on Friday that a potential transaction could value the division at close to $20 billion, citing people familiar with the matter.
According to the report, an agreement could be reached within several weeks. No transaction was confirmed in the supplied information.
Orthopedics Unit Generated $9.3 Billion in 2025
Johnson & Johnson’s orthopedics division generated $9.3 billion in revenue in 2025.
The business has also faced thousands of lawsuits relating to its hip replacement devices.
Johnson & Johnson shares moved higher in pre-market trading as investors assessed the reported discussions and the potential value of a transaction involving the orthopedics unit.
Johnson & Johnson stock price
Apollo Global Management stock price
